177 related articles for article (PubMed ID: 32361482)
1. L-dopa treatment increases oscillatory power in the motor cortex of Parkinson's disease patients.
Cao C; Li D; Zhan S; Zhang C; Sun B; Litvak V
Neuroimage Clin; 2020; 26():102255. PubMed ID: 32361482
[TBL] [Abstract][Full Text] [Related]
2. Beta-band oscillations in the supplementary motor cortex are modulated by levodopa and associated with functional activity in the basal ganglia.
Chung JW; Burciu RG; Ofori E; Coombes SA; Christou EA; Okun MS; Hess CW; Vaillancourt DE
Neuroimage Clin; 2018; 19():559-571. PubMed ID: 29984164
[TBL] [Abstract][Full Text] [Related]
3. Subthalamic nucleus stimulation modulates motor cortex oscillatory activity in Parkinson's disease.
Devos D; Labyt E; Derambure P; Bourriez JL; Cassim F; Reyns N; Blond S; Guieu JD; Destée A; Defebvre L
Brain; 2004 Feb; 127(Pt 2):408-19. PubMed ID: 14691060
[TBL] [Abstract][Full Text] [Related]
4. Levodopa reinstates connectivity from prefrontal to premotor cortex during externally paced movement in Parkinson's disease.
Herz DM; Siebner HR; Hulme OJ; Florin E; Christensen MS; Timmermann L
Neuroimage; 2014 Apr; 90():15-23. PubMed ID: 24269570
[TBL] [Abstract][Full Text] [Related]
5. Effect of l-DOPA on local field potential relationship between the pedunculopontine nucleus and primary motor cortex in a rat model of Parkinson's disease.
Geng X; Wang X; Xie J; Zhang X; Wang X; Hou Y; Lei C; Li M; Han H; Yao X; Zhang Q; Wang M
Behav Brain Res; 2016 Dec; 315():1-9. PubMed ID: 27515286
[TBL] [Abstract][Full Text] [Related]
6. Increased SMA-M1 coherence in Parkinson's disease - Pathophysiology or compensation?
Pollok B; Kamp D; Butz M; Wojtecki L; Timmermann L; Südmeyer M; Krause V; Schnitzler A
Exp Neurol; 2013 Sep; 247():178-81. PubMed ID: 23664959
[TBL] [Abstract][Full Text] [Related]
7. Levodopa Effect and Motor Function in Late Stage Parkinson's Disease.
Rosqvist K; Horne M; Hagell P; Iwarsson S; Nilsson MH; Odin P
J Parkinsons Dis; 2018; 8(1):59-70. PubMed ID: 29480220
[TBL] [Abstract][Full Text] [Related]
8. Movement-related changes in local and long-range synchronization in Parkinson's disease revealed by simultaneous magnetoencephalography and intracranial recordings.
Litvak V; Eusebio A; Jha A; Oostenveld R; Barnes G; Foltynie T; Limousin P; Zrinzo L; Hariz MI; Friston K; Brown P
J Neurosci; 2012 Aug; 32(31):10541-53. PubMed ID: 22855804
[TBL] [Abstract][Full Text] [Related]
9. GABA-mediated changes in inter-hemispheric beta frequency activity in early-stage Parkinson's disease.
Hall SD; Prokic EJ; McAllister CJ; Ronnqvist KC; Williams AC; Yamawaki N; Witton C; Woodhall GL; Stanford IM
Neuroscience; 2014 Dec; 281():68-76. PubMed ID: 25261686
[TBL] [Abstract][Full Text] [Related]
10. Reduction in subthalamic 8-35 Hz oscillatory activity correlates with clinical improvement in Parkinson's disease.
Kühn AA; Kupsch A; Schneider GH; Brown P
Eur J Neurosci; 2006 Apr; 23(7):1956-60. PubMed ID: 16623853
[TBL] [Abstract][Full Text] [Related]
11. Differential modulation of STN-cortical and cortico-muscular coherence by movement and levodopa in Parkinson's disease.
Hirschmann J; Özkurt TE; Butz M; Homburger M; Elben S; Hartmann CJ; Vesper J; Wojtecki L; Schnitzler A
Neuroimage; 2013 Mar; 68():203-13. PubMed ID: 23247184
[TBL] [Abstract][Full Text] [Related]
12. Effect of deep brain stimulation and L-Dopa on electrocortical rhythms related to movement in Parkinson's disease.
Devos D; Defebvre L
Prog Brain Res; 2006; 159():331-49. PubMed ID: 17071241
[TBL] [Abstract][Full Text] [Related]
13. Levodopa Reduces the Phase lag Index of Parkinson's Disease Patients: A Magnetoencephalographic Study.
Cao C; Li D; Zeng K; Zhan S; Huang P; Li X; Sun B
Clin EEG Neurosci; 2019 Mar; 50(2):134-140. PubMed ID: 29914268
[No Abstract] [Full Text] [Related]
14. Effect of L-Dopa on the pattern of movement-related (de)synchronisation in advanced Parkinson's disease.
Devos D; Labyt E; Derambure P; Bourriez JL; Cassim F; Guieu JD; Destée A; Defebvre L
Neurophysiol Clin; 2003 Nov; 33(5):203-12. PubMed ID: 14672820
[TBL] [Abstract][Full Text] [Related]
15. Attenuated beta rebound to proprioceptive afferent feedback in Parkinson's disease.
Vinding MC; Tsitsi P; Piitulainen H; Waldthaler J; Jousmäki V; Ingvar M; Svenningsson P; Lundqvist D
Sci Rep; 2019 Feb; 9(1):2604. PubMed ID: 30796340
[TBL] [Abstract][Full Text] [Related]
16. Differential dopaminergic modulation of spontaneous cortico-subthalamic activity in Parkinson's disease.
Sharma A; Vidaurre D; Vesper J; Schnitzler A; Florin E
Elife; 2021 Jun; 10():. PubMed ID: 34085932
[TBL] [Abstract][Full Text] [Related]
17. Influence of white matter MRI hyper-intensities on acute l-dopa response in patients with Parkinson's disease.
Arena JE; Cerquetti D; Rossi M; Chaves H; Rollan C; Dossi DE; Merello M
Parkinsonism Relat Disord; 2016 Mar; 24():126-8. PubMed ID: 26823237
[TBL] [Abstract][Full Text] [Related]
18. Influence of internal globus pallidus stimulation on motor cortex activation pattern in Parkinson's disease.
Devos D; Derambure P; Bourriez JL; Cassim DF; Blond S; Guieu JD; Destée A; Defebvre L
Clin Neurophysiol; 2002 Jul; 113(7):1110-20. PubMed ID: 12088707
[TBL] [Abstract][Full Text] [Related]
19. Subthalamic Nucleus Deep Brain Stimulation Modulate Catecholamine Levels with Significant Relations to Clinical Outcome after Surgery in Patients with Parkinson's Disease.
Yamamoto T; Uchiyama T; Higuchi Y; Asahina M; Hirano S; Yamanaka Y; Kuwabara S
PLoS One; 2015; 10(9):e0138462. PubMed ID: 26394059
[TBL] [Abstract][Full Text] [Related]
20. Natural history of motor symptoms in Parkinson's disease and the long-duration response to levodopa.
Cilia R; Cereda E; Akpalu A; Sarfo FS; Cham M; Laryea R; Obese V; Oppon K; Del Sorbo F; Bonvegna S; Zecchinelli AL; Pezzoli G
Brain; 2020 Aug; 143(8):2490-2501. PubMed ID: 32844196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
